Perkins Capital Management Inc Castle Biosciences Inc Transaction History

Perkins Capital Management Inc

  • $90.7 Million
  • Q2 2025

A detailed history of Perkins Capital Management Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Perkins Capital Management Inc holds 27,995 shares of CSTL stock, worth $644,164. This represents 0.63% of its overall portfolio holdings.

Number of Shares
27,995
Previous 33,965 17.58%
Holding current value
$644,164
Previous $679,000 15.91%
% of portfolio
0.63%
Previous 0.76%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$15.8 - $21.98 $94,326 - $131,220
-5,970 Reduced 17.58%
27,995 $571,000
Q1 2025

May 07, 2025
SELL
$18.76 - $32.72 $3,752 - $6,544
-200 Reduced 0.59%
33,965 $679,000
Q4 2024

Feb 11, 2025
BUY
$26.52 - $34.67 $40,443 - $52,871
1,525 Added 4.67%
34,165 $910,000
Q3 2024

Oct 31, 2024
BUY
$17.4 - $31.47 $26,969 - $48,778
1,550 Added 4.99%
32,640 $930,000
Q2 2024

Aug 09, 2024
SELL
$18.84 - $24.94 $19,782 - $26,187
-1,050 Reduced 3.27%
31,090 $676,000
Q4 2023

Jan 22, 2024
BUY
$12.19 - $22.43 $36,326 - $66,841
2,980 Added 10.22%
32,140 $694,000
Q3 2023

Nov 02, 2023
SELL
$13.28 - $20.3 $18,924 - $28,927
-1,425 Reduced 4.66%
29,160 $493,000
Q2 2023

Jul 21, 2023
SELL
$11.66 - $26.0 $6,121 - $13,650
-525 Reduced 1.69%
30,585 $420,000
Q3 2022

Oct 24, 2022
SELL
$22.51 - $34.32 $46,370 - $70,699
-2,060 Reduced 6.21%
31,110 $811,000
Q4 2021

Feb 10, 2022
BUY
$39.06 - $67.58 $781 - $1,351
20 Added 0.06%
33,170 $1.42 Million
Q2 2021

Jul 28, 2021
SELL
$50.07 - $76.78 $17,524 - $26,873
-350 Reduced 1.04%
33,150 $2.43 Million
Q1 2021

Apr 28, 2021
SELL
$58.92 - $97.33 $58,920 - $97,330
-1,000 Reduced 2.9%
33,500 $2.29 Million
Q4 2020

Feb 09, 2021
SELL
$43.6 - $73.05 $17,440 - $29,220
-400 Reduced 1.15%
34,500 $2.32 Million
Q3 2020

Oct 28, 2020
BUY
$38.47 - $52.03 $40,393 - $54,631
1,050 Added 3.1%
34,900 $1.8 Million
Q1 2020

Apr 29, 2020
BUY
$23.08 - $35.53 $148,981 - $229,346
6,455 Added 23.56%
33,850 $1.01 Million
Q4 2019

Feb 03, 2020
SELL
$15.74 - $35.04 $8,263 - $18,396
-525 Reduced 1.88%
27,395 $942,000
Q3 2019

Oct 23, 2019
BUY
$18.09 - $27.92 $505,072 - $779,526
27,920 New
27,920 $505,000

Others Institutions Holding CSTL

# of Institutions
168
Shares Held
27.3M
Call Options Held
0
Put Options Held
0
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $605M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email